Sign up to save your podcasts
Or
Share Summarize 2 studies on Iron-Deficiency
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Summarize 2 studies on Iron-Deficiency
Have ever tried to use AI on publications. Not just summarizing, but explore complicated topic in an easy to hear podcast?
This is for you, talking about:
Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia
JAMA. 2020;323(5):432-443. doi:10.1001/jama.2019.22450
Myles Wolf, MD, MMSc; Janet Rubin, MD; Maureen Achebe, MD; Michael J. Econs, MD; Munro Peacock, MD; Erik A. Imel, MD; Lars L. Thomsen, MD; Thomas O. Carpenter, MD; Thomas Weber, MD; Vincent Brandenburg, MD; Heinz Zoller, MD AND
A patient-level cost-effectiveness analysis of iron isomaltoside versus ferric carboxymaltose for the treatment of iron deficiency anemia in the United Kingdom
Journal of Medical Economics, DOI: 10.1080/13696998.2020.1745535
View all episodes
By Dr. V. KaruthHave ever tried to use AI on publications. Not just summarizing, but explore complicated topic in an easy to hear podcast?
This is for you, talking about:
Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia
JAMA. 2020;323(5):432-443. doi:10.1001/jama.2019.22450
Myles Wolf, MD, MMSc; Janet Rubin, MD; Maureen Achebe, MD; Michael J. Econs, MD; Munro Peacock, MD; Erik A. Imel, MD; Lars L. Thomsen, MD; Thomas O. Carpenter, MD; Thomas Weber, MD; Vincent Brandenburg, MD; Heinz Zoller, MD AND
A patient-level cost-effectiveness analysis of iron isomaltoside versus ferric carboxymaltose for the treatment of iron deficiency anemia in the United Kingdom
Journal of Medical Economics, DOI: 10.1080/13696998.2020.1745535